Efficacy of a novel PEGylated humanized anti-TNF fragment (CDP870) in patients with rheumatoid arthritis: a phase II double-blinded, randomized, dose-escalating trial
Year: 2002
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: British journal of rheumatology
Institutions: King's College London, King's College Hospital
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2106964599
